Preoperative Fasting Plasma C-Peptide Levels as Predictors of Remission of Type 2 Diabetes Mellitus after Bariatric Surgery: A Systematic Review and Meta-Analysis

REFERENCES

• Look AHEAD Research Group, WingRR, BolinP, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–154.
   PubMed Web of Science ®Google Scholar
• Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311–321.
   PubMed Web of Science ®Google Scholar
• Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129–2140.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013;310:948–959.
   PubMed Web of Science ®Google Scholar
• Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs. intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013;309:2240–2249.
   PubMed Web of Science ®Google Scholar
• Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet 2012;379:2300–2311.
   PubMed Web of Science ®Google Scholar
• Dixon JB, Zimmet P, Alberti KG, et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabetes Med. 2011;28:628–642.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care 2013;36(Suppl 1):S11–S66.
   PubMed Web of Science ®Google Scholar
• Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20:1245–1250.
   PubMed Web of Science ®Google Scholar
• Hamza N, Abbas MH, Darwish A, et al. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis. 2011;7:691–696.
   PubMed Web of Science ®Google Scholar
• Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2013;36:20–26.
   PubMed Web of Science ®Google Scholar
• Panunzi S, De Gaetano A, Carnicelli A, et al. Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis. Ann Surg. 2015;261:459–467.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zeng G, Tan J, et al. Impact of Roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review. Diabetes Metab Res Rev. 2015;31:653–662.
   PubMed Web of Science ®Google Scholar
• Liang H, Guan W, Yang Y, et al. Roux-en-Y gastric bypass for Chinese type 2 diabetes mellitus patients with a BMI < 28 kg/m2: a multi-institutional study. J Biomed Res. 2015;29:112–117.
   PubMed Web of Science ®Google Scholar
• Nguyen KT, Billington CJ, Vella A, et al. Preserved insulin secretory capacity and weight loss are the predominant predictors of glycemic control in patients with type 2 diabetes randomized to Roux-en-Y gastric bypass. Diabetes 2015;64:3104–3110.
   PubMed Web of Science ®Google Scholar
• Dixon JB, Hur KY, Lee WJ, et al. Gastric bypass in type 2 diabetes with BMI <30: weight and weight loss have a major influence on outcomes. Diabetes Med. 2013;30:e127–e134.
   PubMed Web of Science ®Google Scholar
• Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144:427–437.
   PubMed Web of Science ®Google Scholar
• HigginsJPT. Cochrane Collaboration Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]. The Cochrane Collaboration 2011. Available at: www.cochrane-handbook.org.2011. Accessed October 19, (2016)
   Google Scholar
• Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455–463.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Almulaifi A, Chong K, et al. The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI <30 kg/m2. Obes Surg. 2015;25:1772–1778.
   PubMed Web of Science ®Google Scholar
• Yu H, Di J, Bao Y, et al. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2. Surg Obes Relat Dis. 2015;11:6–11.
   PubMed Web of Science ®Google Scholar
• Ramos-Levi AM, Matia P, Cabrerizo L, et al. Statistical models to predict type 2 diabetes remission after bariatric surgery. J Diabetes 2014;6:472–477.
   PubMed Web of Science ®Google Scholar
• Ramos-Leví AM, Matía P, Cabrerizo L, et al. C-peptide levels predict type 2 diabetes remission after bariatric surgery. Nutr Hosp. 2013;28:1599–1603.
   PubMed Web of Science ®Google Scholar
• Yan H, Tang L, Chen T, et al. Defining and predicting complete remission of type 2 diabetes: a short-term efficacy study of open gastric bypass. Obes Facts 2013;6:176–184.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Chong K, Chen JC, et al. Predictors of diabetes remission after bariatric surgery in Asia. Asian J Surg 2012;35:67–73.
   PubMed Web of Science ®Google Scholar
• Malapan K, Goel R, Tai CM, et al. Laparoscopic Roux-en-Y gastric bypass for non-obese type II diabetes mellitus in Asian patients. Surg Obes Relat Dis. 2014;10:834–840.
   PubMed Web of Science ®Google Scholar
• Chen YF, Yang F, YangYL, et al. Efficacy of modified Roux-en-Y gastric bypass in the treatment of non-obese type 2 diabetes mellitus: one year follow-up. Zhonghua Wai Ke Za Zhi 2012;50:879–882.
   PubMedGoogle Scholar
• Mallipedhi A, Min T, Prior SL, et al. Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgery. Metabolism 2015, November;64(11):1556–1563. doi:10.1016/j.metabol.2015.08.009. [ Epub August 18, 2015]
   PubMed Web of Science ®Google Scholar
• Gong K, Li K, Zhang N, et al. Gastric bypass procedure for type 2 diabetes patients with BMI <28 kg/m2. Surg Endosc. 2016, July 15. [Epub ahead of print]
   Web of Science ®Google Scholar
• Di J, Zhang H, Yu H, et al. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m2. Surg Obes Relat Dis. 2016, February 12: pii:S1550–S7289(16)00052-6. doi:10.1016/j.soard.2016.02.007. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Malin SK, Bena J, Abood B, et al. Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgery. Diabetes Obes Metab. 2014, December;16(12):1230–1238. doi:10.1111/dom.12376. [ Epub September 14, 2014]
   PubMed Web of Science ®Google Scholar
• Lee WJ, Chong K, Ser KH, et al. C-peptide predicts the remission of type 2 diabetes after bariatric surgery. Obes Surg. 2012;22:293–298.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Almulaifi A, Tsou JJ, et al. Laparoscopic sleeve gastrectomy for type 2 diabetes mellitus: predicting the success by ABCD score. Surg Obes Relat Dis. 2015;11:991–996.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Hur KY, Lakadawala M, et al. Predicting success of metabolic surgery: age, body mass index, C-peptide, and duration score. Surg Obes Relat Dis. 2013;9:379–384.
   PubMed Web of Science ®Google Scholar